MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-PB-17-0008441
Rexit Pharmaceutical Private Limited
Rexit Pharmaceutical Private Limited - pharma in Patiala, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.76 Cr
▲ 7% YoY
Net profit · FY 2024
₹3.57 Lakh
Net margin 1.3%
EBITDA · FY 2024
₹6.82 Lakh
EBITDA margin 2.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Rexit Pharmaceutical Private Limited
Data last updated:
Rexit Pharmaceutical Private Limited is a private limited company based in Patiala, Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51909PB2017PTC046135. Its GSTIN is 04AAICR1083R1ZX (Chandigarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nimka Rani and Rakesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 421 Ward No 3 Patran, Patiala, Punjab, India – 147105.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.76 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹3.57 Lakh (net margin 1.3%) and EBITDA of ₹6.82 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 24% over five years.
The company is associated with 1 brand: Rexit Pharmaceutical.
Rexit Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-17-0008441). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909PB2017PTC046135
Registration Number 046135
Incorporation Date 14 February 2017
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-PB-17-0008441
Key People
Nimka Rani Director Rakesh Kumar Director Recognitions & Rankings of Rexit Pharmaceutical
Contact details
Rexit Pharmaceutical Private Limited's registered office is in Patiala, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No 421 Ward No 3 Patran, Patiala, Punjab, India – 147105
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rexit Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Rexit Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Rexit Pharmaceutical operates one associated brand: Rexit Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Wholesaler and trader of pharmaceutical tablets, capsules, syrups, and injections. | rexitpharma.com |
Business activity
The main business activity of Rexit Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rexit Pharmaceutical Private Limited, buy the company report.
Financials of Rexit Pharmaceutical Private Limited
FY 2025 filings availableRexit Pharmaceutical Private Limited reported revenue of ₹2.76 Cr (up 7% YoY) for FY 2024.
Revenue · FY 2024
₹2.76 Cr ▲ 7%
Net profit · FY 2024
₹3.57 Lakh margin 1.3%
EBITDA · FY 2024
₹6.82 Lakh margin 2.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 15%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 14%
5 years · compounded
▲ 48%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 7% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rexit Pharmaceutical Private Limited, buy the company report.
Board of directors of Rexit Pharmaceutical Private Limited
Rexit Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nimka Rani | Director | 14 Feb 2017 | 9 Years 8 Months | Current |
| Rakesh Kumar | Director | 30 Jan 2024 | 2 Years 9 Months | Current |
Peer comparison
Rexit Pharmaceutical Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ashp Veda Private Limited | ₹2.77 Cr (FY 2025) | 63.0% | Jaipur, Rajasthan, India | |||
| Devet India Private Limited | ₹2.77 Cr (FY 2024) | -56.0% | Pune, Maharashtra, India | |||
| Infra Pharmaceuticals Private Limited | ₹2.77 Cr (FY 2025) | -8.0% | Ernakulam, Kerala, India | |||
| Sekisui Chemical India Private Limited | ₹2.77 Cr (FY 2021) | -91.0% | New Delhi, Delhi, India | |||
| Rexit Pharmaceutical Private Limitedthis company | ₹2.76 Cr (FY 2024) | ₹3.57 Lakh | 1.3% | 7.0% | Patiala, Punjab, India | |
| Welfeed Remedies Private Limited | ₹2.76 Cr (FY 2025) | 2.0% | Ahmedabad, Gujarat, India | |||
| Neelkanth Medicare Private Limited | ₹2.75 Cr (FY 2025) | 24.0% | New Delhi, Delhi, India | |||
| Globerian Pharma Private Limited | ₹2.75 Cr (FY 2025) | 5007.0% | Panchkula, Haryana, India | |||
| Cicerone Technologies Private Limited | ₹2.75 Cr (FY 2025) | 20.0% | Gurugram, Haryana, India |
To see the full peer comparison of Rexit Pharmaceutical Private Limited, buy the company report.
Auditor
Rexit Pharmaceutical Private Limited is audited by SHIV BANSAL & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHIV BANSAL & CO | FY 2019 | 021339N |
Shareholding
The shareholding of Rexit Pharmaceutical Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Rexit Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rexit Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rexit Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rexit Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAICR1083R1ZX | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rexit Pharmaceutical Private Limited, buy the company report.
Recent activity
Rexit Pharmaceutical Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Rakesh Kumar was appointed as Director on 30 Jan 2024.
AGM
Rexit Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rexit Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Rakesh Kumar was appointed as Director.
Ceased
Satish Kumar ceased to be Director.
Ceased
Rajesh Kumar ceased to be Director.
Ceased
Rohit Goyal ceased to be Director.
Appointed
Nimka Rani was appointed as Director.
Incorporation
14 Feb 2017
Rexit Pharmaceutical Private Limited was registered on 14 Feb 2017 with Roc Chandigarh & aged 9 years 8 months as per MCA records.
Frequently asked questions
Rexit Pharmaceutical is an active private limited company based in Patiala, Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 February 2017 (9+ years old) and is registered under CIN U51909PB2017PTC046135.
Rexit Pharmaceutical has 2 current directors:
- Nimka Rani - Director
- Rakesh Kumar - Director
The latest financial statements of Rexit Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Rexit Pharmaceutical is 04AAICR1083R1ZX, registered in Chandigarh.
The CIN (Corporate Identification Number) of Rexit Pharmaceutical is U51909PB2017PTC046135. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rexit Pharmaceutical was incorporated on 14 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Rexit Pharmaceutical by revenue are Ashp Veda Private Limited, Devet India Private Limited, Infra Pharmaceuticals Private Limited, Sekisui Chemical India Private Limited, Welfeed Remedies Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rakesh Kumar was appointed as Director on 30 Jan 2024. Satish Kumar ceased to be Director on 30 Jan 2024. Rajesh Kumar ceased to be Director on 10 Sep 2019. Rexit Pharmaceutical has 5 board changes on record in total.
Yes, Rexit Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-17-0008441).
The registered office of Rexit Pharmaceutical is at House No 421 Ward No 3 Patran, Patiala, Punjab, India – 147105.
Rexit Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages